Lupin launches connected Smart Device-Adhero in India
Lupin launches connected Smart Device-Adhero in India

Lupin launches connected Smart Device-Adhero in India

DSIJ Intelligence Article rating: 3.0

Lupin has launched 'Adhero', which is the first-of-its-kind, connected smart device in India to track usage pattern of metered dose inhaler (MDI) by patients. The pharma major also announced the rollout of Hydrocortisone Valerate Cream USP, 0.2%, which is for the relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients.

Dr. Reddy's Laboratories announces the launch of Doxercalciferol Injection
Dr. Reddy's Laboratories announces the launch of Doxercalciferol Injection

Dr. Reddy's Laboratories announces the launch of Doxercalciferol Injection

DSIJ Intelligence Article rating: 3.5

Dr. Reddy's has launched Doxercalciferol Injection, 4 mcg/2 ml (2 mcg/ml) multiple-dose vials, a therapeutic generic equivalent of Hectorol (doxercalciferol) Injection 4 mcg/2 ml (2 mcg/ml) multiple-dose vials, which has been approved by the U.S. Food and Drug Administration (USFDA).

IPO Analysis: CSB Bank
IPO Analysis: CSB Bank

IPO Analysis: CSB Bank

DSIJ Intelligence Article rating: 3.5

CSB Bank, one of the oldest private sector banks in India, with a history of over 98 years, is entering the capital market with its initial public offering. Read on to find if you should subscribe to it.

Coal India to develop new coal mines
Coal India to develop new coal mines

Coal India to develop new coal mines

Amir Shaikh Article rating: 5.0

Coal India is planning to develop 55 new coal mines and expand 193 existing ones in the next five years. The company is also undertaking portal-based monitoring of ongoing projects to ensure its timely completion.


Alembic Pharma gets USFDA approval for 3 ANDAs
Alembic Pharma gets USFDA approval for 3 ANDAs

Alembic Pharma gets USFDA approval for 3 ANDAs

Apurva Joshi Article rating: 5.0

Alembic Pharmaceuticals Limited has received the US Food & Drug Administration (USFDA) approvals for 3 of its ANDAs. It has total of 107 ANDA approvals (95 final approvals and 12 tentative approvals) from the USFDA.

How your financial advisers are getting paid?
How your financial advisers are getting paid?

How your financial advisers are getting paid?

DSIJ Intelligence Article rating: 4.1

Whether you invest in mutual funds or in stocks, your financial advisers or brokers are paid for the services they provide. But, do you know in what ways you pay them? Let’s find out.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

DSIJ Intelligence Article rating: 3.8

The market opened lower on Friday November 22. The previous day witnessed the sensex going down by 76.47 points to close at 40,575.17, while Nifty was down 30.70 points to close at 11,968.40



Finolex Cable introduced new products in FMEG segment
Finolex Cable introduced new products in FMEG segment

Finolex Cable introduced new products in FMEG segment

Amir Shaikh Article rating: 3.3

Finolex Cable informed the bourses on Thursday that it has introduced a fast-moving range of electrical wire accessories. Finolex first entered the electrical switches and lighting segment, leveraging its widespread distribution network in the country.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

DSIJ Intelligence Article rating: 4.0

The market opened lower on Friday November 22. The previous day witnessed the Sensex going down by 76.47 points to close at 40,575.17, while Nifty was down 30.70 points to close at 11,968.40

Do expenses on advertisement impact a companys stock price?
Do expenses on advertisement impact a companys stock price?

Do expenses on advertisement impact a companys stock price?

DSIJ Intelligence Article rating: 2.5

Advertising greatly impacts the revenue and profit of a company, which in turn, put strong influence on its stock market prices. Although these are indirect effects of advertising on stock prices, it can also have a direct effect on the valuation.


RSS
First31093110311131123114311631173118Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR